Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,404,533
-$2,996,649 QoQ
Shares Held
58,608
-21.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#491
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Curi Capital, LLC holds $231,661,896 across 11 Drug Manufacturers - General names. GILD ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,624 | $78,711,400 | |
| 2 | MRK |
Merck & Co., Inc.
|
375,369 | $48,234,916 | |
| 3 | AZN |
Astrazeneca PLC
|
119,992 | $22,752,882 | |
| 4 | JNJ |
Johnson & Johnson
|
88,578 | $22,496,153 | |
| 5 | ABBV |
AbbVie Inc.
|
88,110 | $22,172,000 | |
| 6 | NVS |
Novartis AG
|
114,209 | $17,898,833 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
58,608 | $7,404,533 | |
| 8 | AMGN |
Amgen Inc
|
19,312 | $6,993,261 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,404,533 | 58,608 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $10,401,182 | 74,630 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,716,306 | 87,309 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $9,788,313 | 88,183 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,518,284 | 103,890 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $8,916,602 | 79,577 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,807,481 | 84,524 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,365,344 | 87,850 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $5,972,157 | 87,045 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,247,712 | 85,293 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,401,248 | 79,018 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,035,743 | 67,197 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,056,408 | 65,608 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,090,790 | 61,357 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,043,535 | 47,100 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,210,599 | 35,834 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,069,127 | 17,297 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $531,839 | 8,946 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $651,674 | 8,975 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $628,370 | 8,996 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $617,467 | 8,967 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $579,537 | 8,967 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $524,340 | 9,000 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $588,741 | 9,317 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $720,081 | 9,359 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,417,972 | 18,967 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||